Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07268807

Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease

Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease: A Single-Centre Retrospective Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Zhongda Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Previous clinical observations of potential benefit from Roxadustat in this complex patient population prompted this investigation Therefore, the investigators designed this retrospective, observational study to thoroughly investigate the effects of Roxadustat on heart failure treatment and ventricular remodelling in this specific patient population, aiming to provide new insights for patients management.

Conditions

Interventions

TypeNameDescription
DRUGRoxadustattreated by Roxadustat

Timeline

Start date
2025-12-01
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2025-12-08
Last updated
2025-12-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07268807. Inclusion in this directory is not an endorsement.

Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease (NCT07268807) · Clinical Trials Directory